Lymph node dissection in the lateral neck for completion in central node-positive papillary thyroid cancer

Surgery

Volumn 145, Issue 2, 2009, Pages 176-181

  Machens, Andreas ^a   Hauptmann, Steffen ^a   Dralle, Henning ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; THYROID CANCER; THYROIDECTOMY; TREATMENT OUTCOME;

ADULT; CARCINOMA, PAPILLARY; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NECK; NECK DISSECTION; RETROSPECTIVE STUDIES; THYROID NEOPLASMS;

EID: 58349097350     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surg.2008.09.003     Document Type: Article

References (24)

1. Machens A., Hinze R., Thomusch O., and Dralle H. Pattern of nodal metastasis for primary and reoperative thyroid cancer. World J Surg 26 (2002) 22-28
2. Leboulleux S., Rubino C., Baudin E., Caillou B., Hartl D.M., Bidart J.M., et al. Prognostic factors for persistent or recurrent disease of papillary thyroid carcinoma with neck lymph node metastases and/or tumor extension beyond the thyroid capsule at initial diagnosis. J Clin Endocrinol Metab 90 (2005) 5723-5729
3. White M.L., Gauger P.G., and Doherty G.M. Central lymph node dissection in differentiated thyroid cancer. World J Surg 31 (2007) 895-904
4. Tisell L.E., Hansson G., Jansson S., and Salander H. Reoperation in the treatment of asymptomatic metastasizing medullary thyroid carcinoma. Surgery 99 (1986) 60-66
5. Dralle H., Damm I., and Scheumann G.F. Compartment-oriented microdissection of regional lymph nodes in medullary thyroid carcinoma. Surg Today 24 (1994) 112-121
6. Pacini F., Molinaro E., Castagna M.G., Agate L., Elisei R., Ceccarelli C., et al. Recombinant human thyroglobulin-stimulated serum thyroglobulin combined with neck ultrasonography has the highest sensitivity in monitoring differentiated thyroid carcinoma. J Clin Endocrinol Metab 88 (2003) 3668-3673
7. Grodski S., Cornford L., Sywak M., Sidhu S., and Delbridge L. Routine level VI lymph node dissection for papillary thyroid cancer: surgical technique. ANZ J Surg 77 (2007) 203-208
8. Cooper D.S., Doherty G.M., Haugen B.R., Kloos R.T., Lee S.L., Mandel S.J., et al. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 16 (2006) 109-142
9. Pacini F., Schlumberger M., Dralle H., Elisei R., and Smit J.W.A. Wiersinga W, and the European Thyroid Cancer Taskforce. European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol 154 (2006) 787-803
10. Machens A., Hauptmann S., and Dralle H. Prediction of lateral lymph node metastases in medullary thyroid cancer. Br J Surg 95 (2008) 586-591
11. Röher H.D., Simon D., and Goretzki P.E. [Guidelines in oncologic surgery: malignant thyroid tumors.] Langenbecks Arch Chir Suppl Kongressbd 114 (1997) 142-145
12. Hinze R., Holzhausen H.J., Gimm O., Dralle H., and Rath F.W. Primary hereditary medullary thyroid carcinoma-C-cell morphology and correlation with preoperative calcitonin levels. Virchows Arch 433 (1998) 203-208
13. Bland J.M., and Altman D.G. Multiple significance tests: the Bonferroni method. Br Med J 310 (1995) 170
14. Machens A., Hinze R., Lautenschläger C., Thomusch O., and Dralle H. Thyroid carcinoma invading the cervicovisceral axis: routes of invasion and clinical implications. Surgery 129 (2001) 23-28
15. Yamashita H., Noguchi S., Murakami N., Kawamoto H., and Watanabe S. Extracapsular invasion of lymph node metastasis is an indicator of distant metastasis and poor prognosis in patients with thyroid papillary carcinoma. Cancer 80 (1997) 2268-2272
16. Ito Y., Hirokawa M., Jikuzono T., Higashiyama T., Takamura Y., Miya A., et al. Extranodal tumor extension to adjacent organs predicts a worse cause-specific survival in patients with papillary thyroid carcinoma. World J Surg 31 (2007) 1194-1201
17. Swyak M., Cornford L., Roach P., Stalberg P., Sidhu S., and Delbridge L. Routine ipsilateral level VI lymphadenectomy reduces postoperative thyroglobulin levels in papillary thyroid cancer. Surgery 140 (2006) 1000-1007
18. Kouvaraki M.A., Lee J.E., Shapiro S.E., Sherman S.I., and Evans D.B. Preventable reoperations for persistent and recurrent papillary thyroid carcinoma. Surgery 136 (2004) 1183-1191
19. Bachelot A., Cailleux A.F., Klain M., Baudin E., Ricard M., Bellon N., et al. Relationship between tumor burden and serum thyroglobulin levels in patients with papillary and follicular thyroid carcinoma. Thyroid 12 (2002) 707-711
20. Heemstra K.A., Liu Y.Y., Stokkel M., Kievit J., Corssmit E., Pereira A.M., et al. Serum thyroglobulin concentrations predict disease-free remission and death in differentiated thyroid carcinoma. Clin Endocrinol 66 (2007) 58-64
21. Pereira J.A., Jimeno J., Miquel J., Iglesias M., Munné A., Sancho J.J., et al. Nodal yield, morbidity, and recurrence after central neck dissection for papillary thyroid carcinoma. Surgery 138 (2005) 1095-1101
22. Machens A., Holzhausen H.J., and Dralle H. Contralateral cervical and mediastinal lymph node metastasis in medullary thyroid cancer: systemic disease?. Surgery 139 (2006) 28-32
23. Ohshima A., Yamashita H., Noguchi S., Uchino S., Watanabe S., Toda M., et al. Indications for bilateral modified radical neck dissection in patients with papillary carcinoma of the thyroid. Arch Surg 135 (2000) 1194-1198
24. Palazzo F.F., Grosnell J., Savio R., Reeve T.S., Sidhu S.B., Sywak M.S., et al. Lymphadenectomy for papillary thyroid cancer: changes in practice over four decades. Eur J Surg Oncol 32 (2006) 340-344